Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-9803 in Advanced Solid Tumors
NCT06906731Phase 2Not yet recruiting
- Sponsor
- Hengrui
- Start
- Apr 2025
- Primary completion
- Jun 2027
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of SHR-9803 in solid tumor (advanced stage), sponsored by Hengrui. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
SHR-9803
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06906731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06906731.